UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048900
Receipt number R000055083
Scientific Title Establishment of expanded newborn screening system in Tokyo metropolitan
Date of disclosure of the study information 2022/09/09
Last modified on 2022/09/09 18:48:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of expanded newborn screening system in Tokyo metropolitan

Acronym

Establishment of expanded newborn screening system in Tokyo metropolitan

Scientific Title

Establishment of expanded newborn screening system in Tokyo metropolitan

Scientific Title:Acronym

Establishment of expanded newborn screening system in Tokyo metropolitan

Region

Japan


Condition

Condition

Spiral Muscular Atrophy, Severe Combinede Immunodeficiency, Pompe Disease, Mucopolysaccharidosis type I & II, Fabry disease

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Establishment of expanded newborn screening system in Tokyo metropolitan (target disease: spiral muscular atrophy, severe combinded immunodeficiency, Pompe disease, mucopolysaccharidosis type I & II and Fabry disease)

Basic objectives2

Others

Basic objectives -Others

A pillot study of expanded newborn screening conducted for newborns born at Jikei university hospital and Gonohashi obstetrics and gynecology hospital

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of target disease

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Expanded newborn screening

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 days-old <=

Age-upper limit

28 days-old >=

Gender

Male and Female

Key inclusion criteria

Newborns born at Jikei University Hospital and Gonohashi Obstetrics and Gynecology Hospital with the consent of their parents

Key exclusion criteria

Newborns who died within day 3

Target sample size

4000


Research contact person

Name of lead principal investigator

1st name Masahisa
Middle name
Last name Kobayashi

Organization

The Jikei University School of Medicine

Division name

Department of Pediatrics

Zip code

105-8461

Address

3-25-8 Nishishinbashi Minato-ku, Tokyo

TEL

03-3433-1111

Email

masa-koba@jikei.ac.jp


Public contact

Name of contact person

1st name Masahisa
Middle name
Last name Kobayashi

Organization

The Jikei University School of Medicine

Division name

Department of Pediatrics

Zip code

105-8461

Address

3-25-8 Nishishinbashi Minato-ku, Tokyo

TEL

03-3433-1111

Homepage URL


Email

masa-koba@jikei.ac.jp


Sponsor or person

Institute

Department of Pediatrics, The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Tokyo Health Service Association

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Jikei University School of Medicine

Address

3-25-8 Nishishinbashi Minato-ku, Tokyo

Tel

03-3333-1111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 02 Month 14 Day

Date of IRB

2022 Year 03 Month 14 Day

Anticipated trial start date

2022 Year 07 Month 18 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 09 Month 09 Day

Last modified on

2022 Year 09 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055083


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name